Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

13.81

-0.22 (-1.57%)

At close: Mar 11, 2026, 4:00 PM EDT

13.80

-0.01 (-0.07%)

After-hours: Mar 11, 2026, 4:10 PM EDT

Theravance Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	174.77	37.8	39.55	298.17	89.96	81.47
Short-Term Investments	154.91	50.55	62.88	29.31	83.51	211.47
Cash & Short-Term Investments	329.68	88.35	102.43	327.48	173.47	292.94
Cash Growth	260.85%	-13.74%	-68.72%	88.79%	-40.78%	4.31%
Other Receivables	18.27	68.44	17.47	16.79	57.6	69.67
Total Trade Receivables	18.27	68.44	17.47	16.79	57.6	69.67
Other Current Assets	6.75	4.28	13.64	9.2	18.81	30.73
Total Current Assets	354.7	161.07	133.54	353.46	249.87	393.34
Net Property, Plant & Equipment	31.71	35.77	45.36	52	53.35	59.68
Long-Term Investments	3.03	-	-	-	67.54	12.75
Other Long-Term Assets	26.03	157.32	203.1	201.94	4.07	3.28
Total Assets	415.46	354.16	382	607.4	374.82	469.06
Accounts Payable	2.21	2.24	1.52	1.55	3.1	6.78
Accrued Expenses	20.21	13.28	12.83	20.41	37.95	76.07
Current Portion of Long-Term Debt	-	-	-	-	16.94	19.33
Current Portion of Leases	10.91	10.71	3.92	6.75	0.5	9.87
Unearned Revenue	-	-	-	-	0.1	11.52
Other Current Liabilities	4.07	5.85	6.49	-	-	-
Total Current Liabilities	37.41	32.09	24.77	28.72	58.59	123.57
Long-Term Debt	-	-	-	-	599.39	599.84
Long-Term Leases	33.68	39.11	45.24	45.41	52.68	47.22
Other Long-Term Liabilities	111.69	107.42	99	91.48	2.73	2.18
Total Long-Term Liabilities	145.37	146.53	144.24	136.89	654.81	649.24
Total Liabilities	182.78	178.62	169	165.6	713.39	772.81
Common Stock	0	0	-	0	0	0
Additional Paid-in Capital	1,153	1,141	1,122	1,296	1,387	1,223
Accumulated Other Comprehensive Income	0.03	0.01	-0.07	-0.02	-	0.05
Retained Earnings	-920.65	-965.52	-909.1	-853.91	-1,726	-1,527
Total Common Shareholders' Equity	232.68	175.55	213	441.8	-338.57	-303.75
Shareholders' Equity	232.68	175.55	213	441.8	-338.57	-303.75
Total Liabilities & Equity	415.46	354.16	382	607.4	374.82	469.06
Total Debt	44.6	49.82	49.16	52.16	669.52	676.26
Net Cash (Debt)	285.09	38.53	53.27	275.32	-496.05	-383.32
Net Cash Growth	639.90%	-27.67%	-80.65%	-	-	-
Net Cash Per Share	5.66	0.79	0.96	3.74	-7.14	-6.15
Book Value	232.68	175.55	213	441.8	-338.57	-303.75
Book Value Per Share	4.62	3.59	3.85	6.00	-4.87	-4.87
Tangible Book Value	232.68	175.55	213	441.8	-338.57	-303.75
Tangible Book Value Per Share	4.62	3.59	3.85	6.00	-4.87	-4.87

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q